Damora Therapeutics, Inc. (DMRA) vs GoodRx Holdings, Inc. (GDRX)
A side-by-side comparison of Damora Therapeutics, Inc. and GoodRx Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$20.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GDRX
GoodRx Holdings, Inc.
$3.36HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — DMRA vs GDRX
growth of $100 · dividends reinvested · last 6yDMRA -94.6% (-38.5%/yr)GDRX -93.3% (-36.2%/yr)GDRX compounded faster over this window
DMRA GDRX
DMRA vs GDRX: by the numbers
- •DMRA is the larger company ($1.24B vs $1.16B market cap).
- •GDRX is profitable (2.07% net margin) while DMRA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | DMRA | GDRX |
|---|---|---|
| P/E ratio | N/A | 79.06 |
| P/S ratio | N/A | 1.48 |
| P/B ratio | 3.22 | 1.80 |
| EV / EBITDA | N/A | 8.32 |
| FCF yield | N/A | 12.51% |
Profitability
| Metric | DMRA | GDRX |
|---|---|---|
| Gross margin | 0.00% | 88.05% |
| Operating margin | 0.00% | 10.25% |
| Net margin | 0.00% | 2.07% |
| ROE | -50.93% | 2.51% |
| ROIC | -52.44% | 3.72% |
Growth (annualized)
| Metric | DMRA | GDRX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.47% |
| FCF CAGR (5Y) | N/A | 11.72% |
| Total return CAGR (5Y) | -25.05% | -39.98% |
Frequently asked
- Is DMRA or GDRX more profitable?
- GDRX runs the higher net margin — DMRA at 0.00% versus GDRX at 2.07%.
- How have DMRA and GDRX total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and GDRX delivered -39.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
GoodRx P/E ratioDamora Therapeutics ROEGoodRx ROEDamora Therapeutics operating marginGoodRx operating marginDamora Therapeutics revenue growthGoodRx revenue growthDamora Therapeutics free cash flowGoodRx free cash flow
Damora Therapeutics & GoodRx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.